Health
US to widen inquiry into AstraZeneca COVID vaccine destined for Australia – Sydney Morning Herald
The US regulator has broadened its investigation of a serious illness in AstraZeneca’s COVID-19 vaccine study, a development closely watched by local regulators…
AstraZeneca has confirmed it is still awaiting the green light from US regulators to resume its US trials. The pharma giant’s Australian office wouldn’t comment further on how any delays would affect the timeline for when Australians receive the vaccine if successful.
Meanwhile, there was better news for the vaccine in Europe overnight, with reports the European Medicines Agency is expected to announce a “rolling review” of the Oxford/AstraZeneca candidate this week.
This would mean the Europe…
-
Business20 hours agoIs Warren Buffett’s Berkshire Hathaway the smartest investment you can make today?
-
General20 hours agoTop chess player Magnus Carlsen forced into draw in historic game against over 134,000 people
-
General24 hours agoDeath of 86-year-old driver in Karoonda Highway crash prompts push for change
-
General20 hours agoTaiwan’s President Lai Ching-te calls for peace and dialogue with China while also calling for defence boosts